Sukirti Kalra clinical project manager and Colin Newbould, head of Global Regulatory Affairs & Quality at Wasdell Group examine how clinical trials are adapting with the ongoing Covid-19 pandemic.
Kkolosov Konstantin Kolosov
Clinical trials
Clinical trials are evolving at a rapid pace, with many changes occurring as a direct result of the ongoing global pandemic. COVID-19 has shined a spotlight on how the industry delivers clinical trials, highlighting patient recruitment challenges, logistical hurdles and an urgent demand for new ways to run studies. The need for social distancing has caused many to question whether trials can continue in a clinical setting and how medicines can be supplied to patients.